Effect of portacaval shunt on drug disposition in patients with cirrhosis-Reference-Cited by-同舟云学术

Effect of portacaval shunt on drug disposition in patients with cirrhosis

Published:1986-07 Issue:1 Volume:91 Page:163-167
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Pomier-Layrargues Gilles,Huet P.-Michel,Villeneuve Jean-Pierre,Marleau Denis

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference13 articles.

1. A physiological approach to hepatic drug clearance;Wilkinson;Clin Pharmacol Ther,1975

2. Determinants of drug disposition in patients with cirrhosis;Huet;Hepatology,1983

3. The role of hemodynamic measurements in porto-systemic shunt surgery;Reynolds;Arch Surg,1974

4. The estimation of hepatic blood flow with indocyanine green: comparison between the continuous infusion and single injection methods;Villeneuve;Am J Gastroenterol,1982

5. Effects of smoking and chronic hepatitis B on lidocaine and indocyanine green kinetics;Huet;Clin Pharmacol Ther,1980

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic Impairment Physiologically Based Pharmacokinetic Model Development: Current Challenges;Current Pharmacology Reports;2021-10-01

2. Drug Dosing Considerations for the Critically Ill Patient with Liver Disease;Critical Care Nursing Clinics of North America;2010-09

3. Indocyanine Green Plasma Disappearance Rate During the Anhepatic Phase of Orthotopic Liver Transplantation;Journal of Gastrointestinal Surgery;2007-10-25

4. KICG value, a reliable real-time estimator of graft function, accurately predicts outcomes in adult living-donor liver transplantation;Liver Transplantation;2006

5. Utilisation des médicaments chez le cirrhotique;EMC - Hépatologie;2006-01